abstract |
The present invention relates to novel binding agents and their use in medicine. In particular, the present invention relates to binding agents, such as bispecific antibodies that bind human PD-L1 and bind human CD137. The present invention also relates to the use of the antibodies of the invention and to methods, nucleic acid constructs and host cells for producing the antibodies of the invention. |